Position history for BlackRock, Inc.'s holdings in HAEMONETICS CORP MASS
BlackRock, Inc. holds 5.6M shares of HAE (HAEMONETICS CORP MASS), worth $316.7M as of 2026-Q1. The position was decreased (-3.5% shares). HAE represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$316.7M
Current Shares
5.6M
Total Value Change
-$164.2M
Total Shares Change
-539,925
Other major holders of HAE: Capital Research Global Investors
Decreased |
| 5.6M |
-3.5% |
| $316.7M |
| 0.0% |
| $65.63 |
0 |
| 2025-Q4 | Decreased | 5.8M | -3.3% | $466.5M | 0.0% | $80.98 | 0 |
| 2025-Q3 | Decreased | 6M | -5.4% | $293.4M | 0.0% | $48.12 | 0 |
| 2025-Q2 | Increased | 6.4M | +0.1% | $474.9M | 0.0% | $73.80 | 31 |
| 2025-Q1 | Increased | 6.4M | +3.2% | $404M | 0.0% | $63.19 | 32 |
| 2024-Q4 | New | 6.2M | - | $481M | 0.0% | $76.60 | 43 |